Lawaf Shirin, Azizi Arash, Tabarestani Tohid
Assistant Professor, Department of Prosthodontics, Islamic Azad University, Dental Branch, Tehran, Iran.
Associate Professor, Department of Oral Medicine, Islamic Azad University, Dental Branch, Tehran, Iran.
J Dent (Tehran). 2015 Apr;12(4):263-70.
Temporomandibular dysfunction (TMD) is a group of disorders in the facial region and temporomandibular joint (TMJ). Biomarkers are assumed to play a role in pain and early detection of destruction. The aim of this study was to compare the saliva and serum antioxidant levels in patients with TMD and healthy subjects.
This case-control study was conducted on 28 TMD patients without pain, 28 TMD patients with pain and 28 healthy controls. The total antioxidant capacity of saliva and serum of patients was measured. Data were analyzed using ANOVA and Tamhane's test.
The mean (±SD) total antioxidant capacity of serum (plasma TAC) was 0.8900 (±0.11627) mmol/L in TMD patients with pain, 1.2717 (±0.18711) mmol/L in TMD patients without pain and 1.7500(±0.18711) mmol/L in the control group. Based on ANOVA, the difference in this regard among the three groups was statistically significant (P=0.000). The mean salivary TAC was 1.34 (±0.06721) mmol/L in TMD patients with pain, 1.42 (±0.16677) mmol/L in TMD patients without pain and 1.35 (±0.11627) mmol/L in the control group. The difference in this respect among the three groups was not significant (P>0.05).
The mean plasma TAC in TMD patients with/without pain was significantly lower than that in the control group but no significant difference was detected in salivary TAC among the three groups.
颞下颌关节紊乱病(TMD)是一组累及面部区域和颞下颌关节(TMJ)的疾病。生物标志物被认为在疼痛和破坏的早期检测中发挥作用。本研究的目的是比较TMD患者与健康受试者唾液和血清中的抗氧化剂水平。
本病例对照研究纳入了28例无疼痛的TMD患者、28例有疼痛的TMD患者和28例健康对照者。测量了患者唾液和血清的总抗氧化能力。数据采用方差分析和塔姆黑尼检验进行分析。
有疼痛的TMD患者血清总抗氧化能力(血浆TAC)的均值(±标准差)为0.8900(±0.11627)mmol/L,无疼痛的TMD患者为1.2717(±0.18711)mmol/L,对照组为1.7500(±0.18711)mmol/L。基于方差分析,三组在这方面的差异具有统计学意义(P = 0.000)。有疼痛的TMD患者唾液TAC均值为1.34(±0.06721)mmol/L,无疼痛的TMD患者为1.42(±0.16677)mmol/L,对照组为1.35(±0.11627)mmol/L。三组在这方面的差异不显著(P>0.05)。
有/无疼痛的TMD患者血浆TAC均值显著低于对照组,但三组唾液TAC未检测到显著差异。